Artizan Biosciences is Drug Discovery in United States that focus on central nervous system business. Founded in 2016. They cover business area such as provider, pharmaceutical drug development service, disease, microbiota, its proprietary discovery technology platform, new and potentially curative treatment, unmet medical need, patient, treatment option, a number, digestive disorder, obesity, skin, lung, central nervous system, CNS.
2016
( 8 years old in 2024 )
Central Nervous System
-
25 Science Park at Yale
150 Munson Street, Suite 210
New Haven, CT 06511
United States
Private
providerpharmaceutical drug development servicediseasemicrobiotaits proprietary discovery technology platformnew and potentially curative treatmentunmet medical needpatienttreatment optiona numberdigestive disorderobesityskinlungcentral nervous systemCNS
* We use standard office opening hours in near Artizan Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Artizan Biosciences is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Artizan Biosciences business is focusing on Central Nervous System.
Artizan Biosciences headquarter office and corporate office address is located in 25 Science Park at Yale 150 Munson Street, Suite 210 New Haven, CT 06511 United States.
Artizan Biosciences was founded in United States.
In 2024, Artizan Biosciences is currently focus on central nervous system sector.
Above is snippet of Google Trends for "central nervous system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Artizan Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
